What Drives the Number of High-Risk Human Papillomavirus Types in the Anal Canal in HIV-Positive Men Who Have Sex With Men?P. Rodriguez, Ronald B. Geskus, José Ramón Blanco et al.|The Journal of Infectious Diseases|2013Cited by 40
Pharmacogenetic Predictors of Outcome in Patients with Stage II and III Colon Cancer Treated with Oxaliplatin and Fluoropyrimidine-Based Adjuvant ChemotherapyAna Custodio, Jaime Feliú, Juan Moreno‐Rubio et al.|Molecular Cancer Therapeutics|2014Cited by 12
Data Supplement from Pharmacogenetic Predictors of Outcome in Patients with Stage II and III Colon Cancer Treated with Oxaliplatin and Fluoropyrimidine-Based Adjuvant ChemotherapyAna Custodio, Jaime Feliú, Juan Moreno‐Rubio et al.|Unknown|2023Cited by 0
Data Supplement from Pharmacogenetic Predictors of Outcome in Patients with Stage II and III Colon Cancer Treated with Oxaliplatin and Fluoropyrimidine-Based Adjuvant ChemotherapyAna Custodio, Jaime Feliú, Juan Moreno‐Rubio et al.|Unknown|2023Cited by 0
Data Supplement from Pharmacogenetic Predictors of Outcome in Patients with Stage II and III Colon Cancer Treated with Oxaliplatin and Fluoropyrimidine-Based Adjuvant ChemotherapyAna Custodio, Jaime Feliú, Juan Moreno‐Rubio et al.|Unknown|2023Cited by 0